NCT02753621

Brief Summary

The overall objective of this study is to observe the effect of group Vocal performance training and performance experience on patients' reported symptoms and quality of life. The effectiveness of PD medications varies significantly in different patients depending on their symptoms. By using music-based interventions to improve symptoms that may be inadequately treated by medications, the investigators hope to improve quality of life in PD patients. "Parkinsonics: A controlled study of group singing for quality of life and voice outcomes in Parkinson disease" (PD) is a controlled crossover behavioral intervention study of once weekly choral classes for patients with idiopathic PD (progressing toward a group performance) and once weekly discussion/support group meetings.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for phase_2 parkinson-disease

Timeline
Completed

Started Dec 2015

Shorter than P25 for phase_2 parkinson-disease

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

April 25, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 28, 2016

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2016

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2016

Completed
Last Updated

March 1, 2017

Status Verified

February 1, 2017

Enrollment Period

10 months

First QC Date

April 25, 2016

Last Update Submit

February 28, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Parkinson Disease Quality of Life Questionnaire (PDQ)-39 scores

    Validated 39-item questionnaire

    Change from baseline scores at 30 weeks

Secondary Outcomes (10)

  • Voice-Related Quality of Life

    Change from baseline scores at 30 weeks

  • Movement Disorder Society-Unified Parkinson Disease Rating Scale Motor scores

    Change from baseline scores at 30 weeks

  • Montreal Cognitive Assessment

    Change from baseline scores at 30 weeks

  • Geriatric Depression Scale-15

    Change from baseline scores at 30 weeks

  • Lorig Self-efficacy scale

    Change from baseline scores at 30 weeks

  • +5 more secondary outcomes

Other Outcomes (1)

  • Feasibility

    12 weeks

Study Arms (2)

Singing Intervention

EXPERIMENTAL

Twelve weekly group singing classes lasting 60-90 minutes under the direction of a professional choir director and a social worker with a music background.

Behavioral: Group singing

Discussion/Support Group Intervention

ACTIVE COMPARATOR

Twelve weekly 60-90 minute discussion groups led by a facilitator trained in discussion group facilitation; occurring at the same time and in the same location (next door) as experimental intervention (group singing).

Behavioral: Facilitated Discussion Group

Interventions

Group singingBEHAVIORAL

Weekly group singing classes led by professional choir instructor, lasting 90 minutes. 12 classes over 12 consecutive weeks.

Singing Intervention

Weekly facilitated discussion group led by Parkinson Disease educator, lasting 90 minutes. 12 sessions over 12 consecutive weeks.

Discussion/Support Group Intervention

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of idiopathic PD based on UK Parkinson's Disease Society Brain Bank Clinical Diagnostic Criteria for PD (Hughes et al. 1992).

You may not qualify if:

  • Patients unable to consent to the study.
  • Patients unable or unwilling to participate in weekly singing classes for 12 weeks, or unwilling to perform in a concert setting.
  • Patients with active psychiatric disturbances (agitation, active hallucinations).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Officials

  • Alexander Pantelyat, MD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Neurology

Study Record Dates

First Submitted

April 25, 2016

First Posted

April 28, 2016

Study Start

December 1, 2015

Primary Completion

October 1, 2016

Study Completion

December 31, 2016

Last Updated

March 1, 2017

Record last verified: 2017-02

Data Sharing

IPD Sharing
Will not share